COLUMN GROUP III, LP

Insider profile

COLUMN GROUP III, LP's trades of Tenaya Therapeutics Inc's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
86.28
Quantity 11,925
Value US$4,490,020
Transaction date
Proposed sale
Price
81.66
Quantity 75,606
Value US$4,508,113
Transaction date
Proposed sale
Price
84.08
Quantity 24,972
Value US$1,627,518
Transaction date
Proposed sale
Price
0.79
Quantity 1,408,910
Value US$1,113,038
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-25 2026-02-25 PrS Proposed sale
11,925
86.28
US$4,490,020
11,925 86.28 US$4,490,020
2026-02-20 2026-02-20 PrS Proposed sale
75,606
81.66
US$4,508,113
75,606 81.66 US$4,508,113
2026-02-11 2026-02-11 PrS Proposed sale
24,972
84.08
US$1,627,518
24,972 84.08 US$1,627,518
2026-02-10 2026-02-10 PrS Proposed sale
1,408,910
0.79
US$1,113,038
1,408,910 0.79 US$1,113,038
2020-11-18 2020-11-16 S Sale
1,075,133 -30.7%
36.40
US$39,134,841
1,075,133 -30.7% 36.40 US$39,134,841
2020-11-18 2020-11-16 S Sale
952,023 -30.7%
36.40
US$34,653,637
952,023 -30.7% 36.40 US$34,653,637